The Latest Breaking News from ETF

Stock market bulls fought back Friday, mitigating a bearish week. Palantir was among the winners. A government shutdown crisis is over. Here's what to do now.

There are major divergences and convergences in different ETFs today, which investors need to consider for their portfolios.

The Azoria 500 Meritocracy ETF will shun S&P 500 companies that hire employees based on race and gender rather than skill and merit for better shareholder returns.

Ftures fell as the House rejected a Trump-backed bill to avoid a government shutdown. On Thursday, a market bounce fizzled.

Donald Trump isn't even in the White House yet — but his threats of tariffs are already further pummeling foreign ETFs.

With benefits like diversified exposure, resilience, and relatively stable growth, healthcare ETFs present impressive opportunities for investors. Therefore, it could be wise to buy solid healthcare ETFs like First Trust Health Care AlphaDEX (FXH), iShares Biotechnology (IBB), and iShares U.S. Medical Devices (IHI) to build a resilient portfolio. Read more.

Futures rose after the stock market plunged Wednesday on the Fed rate outlook. Tesla is rebounding. Micron dived on guidance.

Analysts predict “a wave of cryptocurrency ETFs” under incoming SEC chair Paul Atkins.

Here's an easy way to gain broad exposure to the suddenly red-hot quantum computing industry.

ETF experts at Bloomberg believe new crypto ETFs will be approved in 2025, but it may be bad news for those waiting for $SOL and $XRP ETFs.

Futures rise with the Dow in its longest losing streak since 1978 and a Fed rate cut on tap. Nvidia is rebounding. Tesla is falling.